Please login to the form below

Not currently logged in
Email:
Password:

EGFR

This page shows the latest EGFR news and features for those working in and with pharma, biotech and healthcare.

AZ’s immuno-oncology combo fails another lung cancer trial

AZ’s immuno-oncology combo fails another lung cancer trial

There was better news for AZ in cancer last week, after the company picked up FDA approval for its EGFR inhibitor Tagrisso (osimertinib) as a first-line treatment for patients with ... months for patients treated with Tagrisso, compared to 13.8 months

Latest news

More from news
Approximately 5 fully matching, plus 133 partially matching documents found.

Latest Intelligence

  • Harnessing complexity Harnessing complexity

    While more established methodologies still dominate, Next Generation Sequencing is starting to make an impact in the Oncology CDx world, as this breakdown of methodologies used for EGFR mutation testing in

  • Deal Watch November 2015 Deal Watch November 2015

    July finalised a $730m exclusive deal with Boehringer Ingelheim for HM61713, an orally active third generation EGFR agent in small cell lung cancer (SCLC).

  • Transforming times at AstraZeneca Transforming times at AstraZeneca

    in the EGFR-TK gene and Lynparza, which is approved to treat ovarian cancer patients with the BRCA mutation. “

  • Diagnostics are rising up the pharma value chain Diagnostics are rising up the pharma value chain

    These genetic mutations - which also include Epidermal Growth Factor Receptor (EGFR) and Anaplastic Lymphoma Kinase (ALK) in lung cancer - have become targets in medicines research, allowing companies new avenues to develop ... lung cancer, which was

  • Interview: AstraZeneca's Susan Galbraith Interview: AstraZeneca's Susan Galbraith

    EGFR-TK) inhibitor, which has so far been approved in non-small cell lung cancer, albeit after a much-delayed, stop-start regulatory journey. ... If approved, the drug would complement AZ's other NSCLC drug, Iressa, which is approved in NSCLC patients

More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Apex.co.uk Conferences, Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading event and exhibition agencies, specialising in healthcare. We understand your communication goals, whether...

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics